Cancer drug combo slashes risk of death by more than 40%
newatlas.com
A new drug combination to treat advanced recurring prostate cancer has shown remarkable results in a long-term trial, lowering the risk of death after eight years by 40.3%. What's more, the drug treatments are already approved for use on their own.
This is an automated archive made by the Lemmit Bot.

The original was posted on /r/science by /u/mvea on 2025-10-20 10:36:51+00:00.

Original Title: A new drug combination to treat advanced recurring prostate cancer has shown remarkable results in a long-term trial, lowering the risk of death after eight years by 40.3%. What’s more, the drug treatments are already approved for use on their own.